MicroTech Medical (Hangzhou) Co., Ltd.

HKSE 2235.HK

MicroTech Medical (Hangzhou) Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2023: -401.59

MicroTech Medical (Hangzhou) Co., Ltd. Interest Coverage Ratio is -401.59 for the year ending December 31, 2023, a -83.36% change year over year. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.

MicroTech Medical (Hangzhou) Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2022 was -219.02, a 92.27% change year over year.
MicroTech Medical (Hangzhou) Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2021 was -2,831.53, a -588.06% change year over year.
MicroTech Medical (Hangzhou) Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2020 was -411.52, a -53.61% change year over year.
MicroTech Medical (Hangzhou) Co., Ltd. Interest Coverage Ratio for the year ending December 31, 2019 was -267.90.

Key data

Date	Interest Coverage Ratio	Debt to Equity Ratio	Interest Expense To Sales	Inventory Turnover Ratio

HKSE: 2235.HK

MicroTech Medical (Hangzhou) Co., Ltd.

CEO	Dr. Pan Zheng
IPO Date	Oct. 19, 2021
Location	China
Headquarters	No. 108 Liuze Street
Employees	750
Sector	Health Care
Industries Medical Instruments Biotechnology Pharmaceuticals

Description

MicroTech Medical (Hangzhou) Co., Ltd. engages in the research and development, manufacture, and commercialization of diabetes management medical devices and consumables in the People's Republic of China and internationally. Its products include Equil Patch insulin pump systems, AiDEX continuous glucose monitoring systems, POCT analyzer systems, blood glucose monitoring systems, and closed-loop artificial pancreas. The company is also involved in engineering and technology research experimentation and development activities. MicroTech Medical (Hangzhou) Co., Ltd. was incorporated in 2011 and is headquartered in Hangzhou, the People's Republic of China.

Key trends

Past 5 years